Cannabinoid receptor interacting protein 1a interacts with myristoylated Gαi N terminus via a unique gapped β-barrel structure

[1]  W. Lowther,et al.  Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease , 2020, Biomolecules.

[2]  Suwen Zhao,et al.  Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures , 2020, Cell.

[3]  W. Lowther,et al.  Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure , 2019, Molecules.

[4]  W. Blaner,et al.  Abnormal Cannabidiol Modulates Vitamin A Metabolism by Acting as a Competitive Inhibitor of CRBP1. , 2019, ACS chemical biology.

[5]  Ron O. Dror,et al.  Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex , 2019, Cell.

[6]  Anjali D. Ganjiwale,et al.  In silico interaction analysis of cannabinoid receptor interacting protein 1b (CRIP1b) - CB1 cannabinoid receptor. , 2017, Journal of molecular graphics & modelling.

[7]  Shan Jiang,et al.  Crystal structures of agonist-bound human cannabinoid receptor CB1 , 2017, Nature.

[8]  Mostafa H. Ahmed,et al.  CRIP1a inhibits endocytosis of G‐protein coupled receptors activated by endocannabinoids and glutamate by a common molecular mechanism , 2017, Journal of neurochemistry.

[9]  C. Bass,et al.  Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites , 2017, Molecular Pharmacology.

[10]  R. Stevens,et al.  Crystal Structure of the Human Cannabinoid Receptor CB1 , 2016, Cell.

[11]  S. Ismail,et al.  Shuttling and sorting lipid-modified cargo into the cilia. , 2016, Biochemical Society transactions.

[12]  D. Deutsch.  A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs) , 2016, Front. Pharmacol..

[13]  S. Tenzer,et al.  Cell Type-Specific Tandem Affinity Purification of the Mouse Hippocampal CB1 Receptor-Associated Proteome. , 2016, Journal of proteome research.

[14]  A. Wittinghofer,et al.  Novel Biochemical and Structural Insights into the Interaction of Myristoylated Cargo with Unc119 Protein and Their Release by Arl2/3* , 2016, The Journal of Biological Chemistry.

[15]  P. Bastiaens,et al.  Identification of pyrazolopyridazinones as PDEδ inhibitors , 2016, Nature Communications.

[16]  A. Wittinghofer,et al.  PDE6δ-mediated sorting of INPP5E into the cilium is determined by cargo-carrier affinity , 2016, Nature Communications.

[17]  K. Mackie,et al.  An Introduction to the Endogenous Cannabinoid System , 2016, Biological Psychiatry.

[18]  B. Lutz,et al.  The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons , 2015, PLoS biology.

[19]  Jordan O. Cox,et al.  Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation , 2015, Molecular Pharmacology.

[20]  C. Bass,et al.  Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells. , 2015, Cellular signalling.

[21]  D. Deutsch,et al.  Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)* , 2015, The Journal of Biological Chemistry.

[22]  R. Mechoulam,et al.  Early phytocannabinoid chemistry to endocannabinoids and beyond , 2014, Nature Reviews Neuroscience.

[23]  Mostafa H. Ahmed,et al.  Predicting the molecular interactions of CRIP1a-cannabinoid 1 receptor with integrated molecular modeling approaches. , 2014, Bioorganic & medicinal chemistry letters.

[24]  D. Deutsch,et al.  Crystallographic study of FABP5 as an intracellular endocannabinoid transporter. , 2014, Acta crystallographica. Section D, Biological crystallography.

[25]  Joshua M. Kunken,et al.  Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. , 2012, Structure.

[26]  P. Bastiaens,et al.  The GDI-like solubilizing factor PDEδ sustains the spatial organization and signalling of Ras family proteins , 2011, Nature Cell Biology.

[27]  P. Bastiaens,et al.  Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated cargo. , 2011, Nature chemical biology.

[28]  Nathaniel Echols,et al.  The Phenix software for automated determination of macromolecular structures. , 2011, Methods.

[29]  R. Stadel,et al.  The cannabinoid type‐1 receptor carboxyl‐terminus, more than just a tail , 2011, Journal of neurochemistry.

[30]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[31]  L. Hunyady,et al.  Signal transduction of the CB1 cannabinoid receptor. , 2010, Journal of molecular endocrinology.

[32]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[33]  B. Matthews,et al.  Evaluation at atomic resolution of the role of strain in destabilizing the temperature‐sensitive T4 lysozyme mutant Arg 96 → His , 2009, Protein science : a publication of the Protein Society.

[34]  D. Deutsch,et al.  Identification of intracellular carriers for the endocannabinoid anandamide , 2009, Proceedings of the National Academy of Sciences.

[35]  M. Elphick,et al.  CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a , 2007, Molecular Pharmacology.

[36]  Jacqueline Cherfils,et al.  RhoGDIs Revisited: Novel Roles in Rho Regulation , 2005, Traffic.

[37]  J. Couchman,et al.  RhoGDI: multiple functions in the regulation of Rho family GTPase activities. , 2005, The Biochemical journal.

[38]  C. Dermardirossian,et al.  GDIs: central regulatory molecules in Rho GTPase activation. , 2005, Trends in cell biology.

[39]  Yawen Bai,et al.  Redesign of a four-helix bundle protein by phage display coupled with proteolysis and structural characterization by NMR and X-ray crystallography. , 2002, Journal of molecular biology.

[40]  J. Nie,et al.  The proximal and distal C-terminal tail domains of the CB1 cannabinoid receptor mediate G protein coupling , 2001, Neuroscience.

[41]  A. Howlett,et al.  CB1 receptor–G protein association , 2001 .

[42]  S. Narang,et al.  Mutation of active site residues in synthetic T4-lysozyme gene and their effect on lytic activity. , 1988, Biochemical and biophysical research communications.

[43]  B. Matthews,et al.  Use of site-directed mutagenesis to obtain isomorphous heavy-atom derivatives for protein crystallography: cysteine-containing mutants of phage T4 lysozyme. , 1987, Protein engineering.

[44]  Liisa Holm,et al.  Using Dali for Protein Structure Comparison. , 2020, Methods in molecular biology.

[45]  A. Dopico,et al.  Cannabinoid Interactions with Proteins: Insights from Structural Studies. , 2019, Advances in experimental medicine and biology.

[46]  Jihui Wu,et al.  NMR characterization of weak interactions between RhoGDI2 and fragment screening hits. , 2017, Biochimica et biophysica acta. General subjects.

[47]  A. Howlett,et al.  CB1 and CB2 Receptor Pharmacology. , 2017, Advances in pharmacology.

[48]  M. Elphick,et al.  CB 1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1 a , 2007 .

[49]  A. Howlett,et al.  CB1 receptor-G protein association. Subtype selectivity is determined by distinct intracellular domains. , 2001, European journal of biochemistry.